111 (YI) EBT Growth (1y) (2018 - 2025)
111 (YI) EBT Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 40.26% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 124.90% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | -41.05% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 3.45% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | -200.96% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -22.44% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 46.02% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -242.92% |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 46.02% |
| Sep 30, 2025 | 58.99% |
| Jun 30, 2025 | -262.50% |
| Mar 31, 2025 | -174.79% |
| Dec 31, 2024 | 94.05% |
| Sep 30, 2024 | 95.67% |
| Jun 30, 2024 | 95.53% |
| Mar 31, 2024 | 87.05% |
| Dec 31, 2023 | -91.43% |
| Sep 30, 2023 | 5.74% |
| Jun 30, 2023 | 50.55% |
| Mar 31, 2023 | 82.31% |
| Dec 31, 2022 | 5.50% |
| Sep 30, 2022 | 52.88% |
| Jun 30, 2022 | 55.59% |
| Mar 31, 2022 | 38.42% |
| Dec 31, 2021 | 24.18% |
| Sep 30, 2021 | -57.11% |
| Jun 30, 2021 | -116.33% |
| Mar 31, 2021 | -45.98% |